Abstract
The difficulties found in the maturation of the Science of Biomaterials are analysed at the different levels: research, education, industry, reglementary and legislative environment, needs of hospitals and private practices. Proposals are made for a better response to the needs of an area which should have a growth at least as important as that of drugs.
MeSH terms
-
Biocompatible Materials* / chemistry
-
Biocompatible Materials* / classification
-
Biocompatible Materials* / standards
-
Education
-
Equipment and Supplies, Hospital
-
Europe
-
Humans
-
Industry
-
Materials Testing
-
Pharmaceutical Preparations
-
Private Practice
-
Public Health*
-
Research
-
Technology / legislation & jurisprudence
-
United States
-
United States Food and Drug Administration
Substances
-
Biocompatible Materials
-
Pharmaceutical Preparations